Florida Health Daily
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Florida

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on May 12, 2025

Stereotaxis Reports 2025 First Quarter Financial Results

Stereotaxis Reports 2025 First Quarter Financial Results

ST. LOUIS, May 12, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the first quarter ended March 31, 2025. “We’ve …

Xenon Reports First Quarter 2025 Financial Results and Provides Business Update

Xenon Reports First Quarter 2025 Financial Results and Provides Business Update

– Phase 3 azetukalner X-TOLE2 FOS study patient recruitment expected to complete in the next few months with topline data anticipated in early 2026 – Phase 3 azetukalner X-NOVA3 MDD and Phase 3 BPD studies on track to initiate mid-year – Results from …

Syndax Pharmaceuticals Appoints Dr. Nicholas Botwood as Head of Research and Development and Chief Medical Officer

Syndax Pharmaceuticals Appoints Dr. Nicholas Botwood as Head of Research and Development and Chief Medical Officer

- Dr. Nicholas Botwood comes to Syndax from BMS and brings 25 years of industry experience leading drug development, R…

Editas Medicine Announces U.S. Court of Appeals for the Federal Circuit Remands CRISPR Patent Interference to Patent Trial and Appeal Board

Editas Medicine Announces U.S. Court of Appeals for the Federal Circuit Remands CRISPR Patent Interference to Patent Trial and Appeal Board

CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced that the U.S. Court of Appeals for the Federal Circuit affirmed-in-part and vacated-in-part the Patent Trial and …

MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update

MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update

MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update Continued to make significant progress with the development of the Nanobody® sonelokimab across portfolio of indications, including Phase 3 studies in …

BioStem Technologies Reports Preliminary First Quarter 2025 Operating and Financial Results

BioStem Technologies Reports Preliminary First Quarter 2025 Operating and Financial Results

Preliminary net revenue increased 73% to $72.5 million for Q1 2025, compared to $41.9 million in Q1 2024 Achieved preliminary GAAP net income of $4.5 million, or $0.27 per share Reported preliminary Q1 2025 Adjusted EBITDA of $7.8 million Quarter-end cash …

Progyny, Inc. to Present at BofA Securities 2025 Health Care Conference

Progyny, Inc. to Present at BofA Securities 2025 Health Care Conference

NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Progyny’s Chief Executive Officer, Pete Anevski, and Chief Financial Officer, Mark Livingston, …

Siren Biotechnology to Present Universal AAV Immuno-Gene Therapy Data at the 2025 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

Siren Biotechnology to Present Universal AAV Immuno-Gene Therapy Data at the 2025 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

SAN FRANCISCO, May 12, 2025 (GLOBE NEWSWIRE) -- Siren Biotechnology Inc., pioneers of Universal AAV Immuno-Gene Therapy for Cancer, today announced that it will present new scientific data at the 2025 American Society of Gene and Cell Therapy (ASGCT) …

Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure

Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure

TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases and …

Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight

Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight

New York, USA, May 12, 2025 (GLOBE NEWSWIRE) -- Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight The blood cancer market is experiencing robust growth, driven by rising incidence …

Heroes on the Water Observes National Police Week Focusing on Officer Wellness, Cumulative PTSD

Heroes on the Water Observes National Police Week Focusing on Officer Wellness, Cumulative PTSD

Allen, Texas, May 12, 2025 (GLOBE NEWSWIRE) -- National Police Week is a time to remember officers who have made the ultimate sacrifice, and a time to recognize the everyday cost of service carried by those still on the job. This year, Heroes on the Water …

The Joint Commission and National Quality Forum announce recipients of 2024 Eisenberg Patient Safety and Quality Awards

The Joint Commission and National Quality Forum announce recipients of 2024 Eisenberg Patient Safety and Quality Awards

OAKBROOK TERRACE, Illinois, May 12, 2025 (GLOBE NEWSWIRE) -- The Joint Commission and the National Quality Forum (NQF) today announced the recipients of the 2024 John M. Eisenberg Patient Safety and Quality Awards. The Eisenberg Awards, named in honor of …

PacBio Board Independent Investigation Concludes Allegations Unsubstantiated

PacBio Board Independent Investigation Concludes Allegations Unsubstantiated

MENLO PARK, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced that the Special Committee of its Board of Directors (the “Special Committee”) has concluded its independent investigation into previously disclosed allegations from …

Best Cortisol Supplements 2025: CortiSync Under Review & Top Stress Relief Pills That Work

Best Cortisol Supplements 2025: CortiSync Under Review & Top Stress Relief Pills That Work

Limassol, Cyprus, May 12, 2025 (GLOBE NEWSWIRE) -- Introduction: Best Supplements for High Cortisol 2025 – CortiSync Modern life is fast-paced, demanding, and filled with pressures that can take a toll on both the mind and body. At the center of this …

Services-Conseils en Ergonomie devient ERGOVIA

Services-Conseils en Ergonomie devient ERGOVIA

SHERBROOKE, Québec, 12 mai 2025 (GLOBE NEWSWIRE) -- SCE Services-Conseils en Ergonomie devient ERGOVIA. Ce changement de nom s’accompagne d’une toute nouvelle image de marque. Cette évolution s'inscrit dans une démarche stratégique visant à mieux refléter …

Nurses Speak Out on Burnout, Balance, and the Future of the Profession in New Survey

Nurses Speak Out on Burnout, Balance, and the Future of the Profession in New Survey

DALLAS, May 12, 2025 (GLOBE NEWSWIRE) -- While 75% of nurses report being satisfied with their career choice, many still face significant strain due to burnout, mental health challenges, and staffing issues, according to a new survey by AMN Healthcare, the …

InBrain Pharma Secures €1.8 Million in Funding for the PERCEPAR Project under France 2030’s “First Factory” Initiative  to Industrialize Anaerobic Dopamine Production for Parkinson’s Disease

InBrain Pharma Secures €1.8 Million in Funding for the PERCEPAR Project under France 2030’s “First Factory” Initiative to Industrialize Anaerobic Dopamine Production for Parkinson’s Disease

InBrain Pharma Secures €1.8 Million in Funding for the PERCEPAR Project under France 2030’s “First Factory” Initiative to Industrialize Anaerobic Dopamine Production for Parkinson’s Disease Lille, May 12, 2025 – InBrain Pharma, a clinical stage biotech …

Porch Light Health Acquires Comprehensive Behavioral Health Center to Expand Access to Full-Spectrum Addiction Treatment

Porch Light Health Acquires Comprehensive Behavioral Health Center to Expand Access to Full-Spectrum Addiction Treatment

DENVER, May 12, 2025 (GLOBE NEWSWIRE) -- Porch Light Health, the largest addiction medicine practice in Colorado, offering outpatient Medications for Addiction Treatment (MAT) at more than 60 treatment locations, is proud to announce the acquisition of …

Lancement de campagne de prévention au tabagisme chez les jeunes âgé·es de 11 à 15 ans : Laisse pas ta vie partir en fumée

Lancement de campagne de prévention au tabagisme chez les jeunes âgé·es de 11 à 15 ans : Laisse pas ta vie partir en fumée

MONTRÉAL, 12 mai 2025 (GLOBE NEWSWIRE) -- Le RSEQ (Réseau du sport étudiant du Québec) lance Laisse pas ta vie partir en fumée, une campagne annuelle de prévention à l’initiation du tabagisme visant à sensibiliser les jeunes âgés de 11 à 15 ans. Elle vise …

Inspire Launches Patient Community Sponsorships, Offering Life Sciences Unprecedented Access to Condition-Specific, Engaged Populations

Inspire Launches Patient Community Sponsorships, Offering Life Sciences Unprecedented Access to Condition-Specific, Engaged Populations

Arlington, VA, May 12, 2025 (GLOBE NEWSWIRE) -- Inspire, the leading digital community platform for patients and caregivers across more than 3,000 conditions, today announced the launch of its Patient Community Sponsorship program. This new initiative …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service